This bulletin covers the safety considerations of potentially teratogenic medicines. It highlights those with a pregnancy prevention programme in place and the annual risk assessments that need to be completed for females and males where appropriate. It also discusses considerations for some other potentially teratogenic medicines. Audit tools, infobriefs, summary resources for different medicines and a presentation are available as supporting resources.
Please login to view this content
